Skip to main content
Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
10.06
+0.32 (3.29%)
At close: Jun 6, 2025, 4:00 PM
10.04
-0.02 (-0.20%)
After-hours: Jun 6, 2025, 7:20 PM EDT

Evolus Revenue

Evolus had revenue of $68.52M in the quarter ending March 31, 2025, with 15.49% growth. This brings the company's revenue in the last twelve months to $275.46M, up 25.38% year-over-year. In the year 2024, Evolus had annual revenue of $266.27M with 31.76% growth.

Revenue (ttm)
$275.46M
Revenue Growth
+25.38%
P/S Ratio
2.31
Revenue / Employee
$829,708
Employees
332
Market Cap
647.33M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024266.27M64.19M31.76%
Dec 31, 2023202.09M53.47M35.98%
Dec 31, 2022148.62M48.94M49.10%
Dec 31, 202199.67M43.13M76.29%
Dec 31, 202056.54M21.62M61.89%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings

EOLS News

More News